NA
NUVB icon

NewEdge Advisors’s Nuvation Bio NUVB Stock Holding History

NewEdge Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7M Buy
1,231,733
+200,621
+19% +$981K 0.02% 634
2026
Q1 		$4.42M Buy
1,031,112
+78,946
+8% +$440K 0.02% 747
2025
Q4 		$8.53M Buy
+952,166
New +$5.9M 0.03% 486

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

NewEdge Advisors's NUVB Position: Q2 2026 in Review

NewEdge Advisors increased its Nuvation Bio (NUVB) stake by 19% in Q2 2026, buying an estimated $981K and bringing the position to 1,231,733 shares worth $7M. The position accounts for 0.02% of the portfolio, ranked #634.

NewEdge Advisors first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.53M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • NewEdge Advisors held 1,231,733 shares of Nuvation Bio worth $7M as of Q2 2026.
  • NewEdge Advisors bought 200,621 Nuvation Bio shares in Q2 2026, an estimated $981K.
  • Nuvation Bio made up 0.02% of NewEdge Advisors's portfolio in Q2 2026, its #634 holding.
  • NewEdge Advisors first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • NewEdge Advisors's Nuvation Bio position peaked at $8.53M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.